TAB.RUXOLITINIB 10mg

• Firm must upload the certificate, mentioning the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy. The firm has to certify that the item offered meets the minimum local content and shall give details of the locations at which the local value addition is made.

  Document optional

• The tenderers in their bids shall indicate the details of their Jurisdictional Goods and Service Tax (GST) Accessing Officers (Designation, address & email id). In case of a contract award, a copy of the LOA/ Purchase Order shall be immediately forwarded by Purchaser to the Jurisdictional GST Assessing Officer Mentioned in the Tenderer's Bid

  Document optional

Technical-Compliances

• The firm must mention the following in remarks field while submitting the tender offer [a] Brand Name[b] Detailed composition [c] Name of manufacturer of the offered brand [d] MRP

  Document optional

• Firm must mention in remark - MRP of the offered brand

  Document optional

• Part quantity supply, inspection, payment and accountal is permitted. Unloading of material to be done by firm.

• If vendor quotes delivery period as range bound period then the lower value of that range will be considered for delivery period.

• Each strip/packet/bottle that contains the drug should have a printing/stamping with indelible ink of SECR Not for sale. Firms are advised to put their Holograms on their product/cartons.

• Analysis report for each batch from manufacturer's own laboratory / Govt. recognized laboratory must accompany the consignment without fail on supply of each batch of medicine.

• The remaining shelf life of the offered product should not be less than 80% of total shelf life or it should not be older than 06 months from the date of manufacture (whichever is more) at the time of supply. In specific cases, PCMD may relax this condition on case to case basis with the written under taking by the manufacturing firm that the firm will replace unused quantity free of cost before the expiry date of that item with fresh batch .

• The firm to whom the order is issued bears the exclusive responsibility for the proper execution and fulfillment of the contract, regardless of whether the supply is facilitated through an Original Equipment Manufacturer (OEM)

• Whenever drug samples on analysis are found to be not conforming to standards, the firms/suppliers are required to replace the whole batch free of cost with another batch from a different manufacturing unit to all the consignees, irrespective of whether the batch has been used completely/partially or not.

• The contract with the stockiest/authorized importer will remain valid till such authorization exists and in the event of discontinuation of authorization by the principal firm, the contract with the supplier will be deemed to have terminated and fresh P.O. will be issued in favour of new supplier appointed by the principal. No confirmation from the distributor/supplier is necessary in these cases.